S 
0.05
+4.17%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in AUD, from our data supplier.
Revenue, before interest expense
A$105.4m
FY2017FY2026
Net income
−A$8.6m
FY2017FY2026
Total assets
A$53.1m
FY2017FY2026
Shareholders' equity
A$36.0m
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | A$105.4m | A$119.0m | A$124.6m | A$98.5m | A$110.4m | A$116.5m | A$84.5m | A$74.3m | A$58.3m | A$24.3m |
| Research and development | — | — | — | A$0 | A$0 | A$0 | A$0 | A$0 | A$0 | A$0 |
| Operating income | A$2.5m | A$9.9m | A$4.7m | A$4.6m | A$6.4m | A$8.3m | A$1.9m | −A$1.0m | A$4.7m | A$1.7m |
| Net income | −A$8.6m | A$3.2m | A$24.0m | −A$2.6m | A$5.7m | A$5.5m | A$1.9m | −A$1.0m | A$2.3m | A$709,799 |
| Diluted earnings per share | -0.07 | 0.03 | 0.19 | -0.02 | 0.04 | 0.04 | 0.01 | -0.01 | 0.02 | 0.01 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | A$53.1m | A$73.0m | A$79.4m | A$135.7m | A$135.9m | A$142.4m | A$101.3m | A$96.9m | A$114.5m | A$65.1m |
| Cash and short-term investments | A$1.6m | A$4.4m | A$22.0m | A$10.9m | A$38.2m | A$34.6m | A$23.0m | A$18.9m | A$19.0m | A$6.2m |
| Total liabilities | A$17.2m | A$24.6m | A$22.7m | A$92.7m | A$87.5m | A$101.3m | A$68.0m | A$65.7m | A$86.8m | A$54.9m |
| Debt | A$2.5m | A$4.6m | A$704,641 | A$4.2m | A$2.9m | A$3.3m | A$4.3m | A$1.4m | A$7.4m | A$1.7m |
| Shareholders' equity | A$36.0m | A$48.5m | A$56.7m | A$43.0m | A$48.4m | A$41.1m | A$33.2m | A$31.2m | A$27.8m | A$10.1m |
| Shares outstanding | 123m | 123m | 125m | 135m | 138m | 136m | 131m | 120m | 116m | 68m |
Latest quarters
By quarter end
| Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | A$42.1m | A$63.4m | A$60.9m | A$58.1m | A$59.2m | A$62.8m | A$37.4m | A$43.5m |
| Operating income | −A$1.2m | A$3.7m | A$7.1m | A$2.7m | A$5.5m | A$1.2m | −A$355,000 | A$1.4m |
| Net income | −A$8.3m | −A$248,815 | −A$374,261 | A$3.6m | −A$3.9m | A$1.6m | −A$3.3m | A$630,510 |
| Diluted earnings per share | -0.07 | -0.00 | -0.00 | 0.03 | -0.03 | 0.01 | -0.02 | 0.00 |
| Total assets | A$53.1m | A$66.8m | A$73.0m | A$75.8m | A$79.4m | A$86.5m | A$135.7m | A$110.2m |
| Cash and short-term investments | A$1.6m | A$2.5m | A$4.4m | A$10.9m | A$22.0m | A$18.3m | A$9.4m | A$31.8m |
| Debt | A$718,061 | A$3.0m | A$4.0m | A$1.9m | A$704,642 | A$774,905 | A$3.2m | A$2.4m |
| Shareholders' equity | A$36.0m | A$45.5m | A$48.5m | A$51.5m | A$56.7m | A$63.9m | A$43.0m | A$47.2m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.3% | -2.0% | 24.8% |
| Operating income | -18.9% | -21.6% | — |
| Net income | 48.3% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 5.5% | 4.8% | 5.4% | 3.5% |
| Net margin | -2.4% | 3.6% | 4.0% | 3.4% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -0.7 | 11.1 | 2.0 | -28.8 | 14.2 | 16.7 | 33.8 | -27.0 | 13.6 | 29.8 |
| Price to sales | 0.1 | 0.3 | 0.4 | 0.8 | 0.7 | 0.8 | 0.8 | 0.4 | 0.5 | 0.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 6 years. Last went ex-dividend on 30 Mar 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Paid in the year | 0.015 | 0.001 | 0.001 | 0.023 | 0.016 | 0.011 | 0.007 |
- 100-to-1 reverse split · 3 Nov 2016
- 1-to-1 reverse split · 21 Jul 2005
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.